University of California, Los Angeles
Los Angeles, California, United States
Purpose
to assess the safety and acceptability of a new combination of HIV medicines that are expected to become the new first line treatment.
Division
Global Health
Date
May 2019
Region Served
AFRICA, AMERICA
Committed amount
$100,000
Grant topic
HIV
Duration (months)
67
Grantee location
Los Angeles, California, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.